As of November 6, 2026, one holder's latest Schedule 13D or 13G filing report owning 5% or more of Firefly Neuroscience, Inc. The largest reported stake is Windsor Private Capital LP's, at 5%. 7 filings are on record since October 15, 2025 (Schedule 13D/A, January 30, 2026).
Sell to companies like Firefly Neuroscience, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Holder: Windsor Private Capital LP · Percent: 5% · SCHEDULE 13D/A
- · Holder: Windsor Private Capital LP · Percent: 6.1% · SCHEDULE 13D/A
- · Holder: Windsor Private Capital LP · Percent: 7.5% · SCHEDULE 13D/A
- · Holder: Arena Investors, LP · Percent: 0% · SCHEDULE 13G/A
- · Holder: Windsor Private Capital LP · Percent: 8.7% · SCHEDULE 13D/A
Firefly Neuroscience, Inc. has 7 Schedule 13D or 13G filings on record since 2025-10-15. 1 holder's latest filing reports 5% or more of common stock, $0.0001 par value per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Windsor Private Capital LP | 5% | 605,421 | SCHEDULE 13D/A, 2026-01-30 | 2026-01-28 |
| Arena Investors, LP | 0% | 0 | SCHEDULE 13G/A, 2025-11-14 | 2025-03-31 |
Holding shares or following this stake? See who's behind Firefly Neuroscience, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Firefly Neuroscience, Inc. and the records around it.
Firefly Neuroscience, Inc. elsewhere on the record
- Company profile and every filing Apr 2026
- Form D filing Apr 2026
- Form D filing Jun 2025
- Who owns it
Companies that share a holder
- Arena Investors, LP also filed stake reports on 10 other companies: RenX Enterprises Corp. (Feb 2026), RYVYL Inc. (Feb 2026), OceanPal Inc. (Nov 2025)
Watch Firefly Neuroscience, Inc.
Get an email when Firefly Neuroscience, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Firefly Neuroscience, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Firefly Neuroscience, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Firefly Neuroscience, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
10 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Purpose of Transaction (Item 4)
Windsor Private Capital LP
As further described in Item 5(c) below, the Reporting Persons sold an aggregate of 147,300 Common Shares between December 31, 2025 and January 30, 2026. As a result of the transactions described herein, the Reporting Persons have ceased to be the beneficial owners of more than 5% of the outstanding Common Shares, as disclosed on the cover pages of this Amendment No. 6. Accordingly, the filing of this Amendment No. 6 constitutes an exit filing for the Reporting Persons.Item 4 of the SCHEDULE 13D/A filed 2026-01-30
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-10-15 | Windsor Private Capital LP | 11.3% | SCHEDULE 13D/A |
| 2025-10-23 | Windsor Private Capital LP | 9.7% | SCHEDULE 13D/A |
| 2025-11-07 | Windsor Private Capital LP | 8.7% | SCHEDULE 13D/A |
| 2025-11-14 | Arena Investors, LP | 0% | SCHEDULE 13G/A |
| 2025-12-09 | Windsor Private Capital LP | 7.5% | SCHEDULE 13D/A |
| 2025-12-31 | Windsor Private Capital LP | 6.1% | SCHEDULE 13D/A |
| 2026-01-30 | Windsor Private Capital LP | 5% | SCHEDULE 13D/A |
Questions about who owns Firefly Neuroscience, Inc.
Who owns Firefly Neuroscience, Inc.?
On this page, one holder's latest ownership filing reports 5% or more of Firefly Neuroscience, Inc.: Windsor Private Capital LP (5%, Schedule 13D/A, filed 2026-01-30).
When did Windsor Private Capital LP buy into Firefly Neuroscience, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Windsor Private Capital LP on this page is the Schedule 13D/A, filed 2025-10-15, reporting 11.3%; its latest, Schedule 13D/A filed 2026-01-30, reports 5%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 7 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for Firefly Neuroscience, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| September 14, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| April 16, 2026 | Form D, private offering | $2.25M sold | Form D page | Source |
| June 23, 2025 | Form D, private offering | $1.20M sold | Form D page | Source |
Firefly Neuroscience, Inc.: every filing and event
Tools for this story
Each opens in a new tab, filled in for Firefly Neuroscience, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.